Patent classifications
C07C211/38
Memantine pamoate, method of preparation and use thereof
The composition containing a pamoate salt of donepezil, the method of preparation and the use thereof are disclosed.
Memantine pamoate, method of preparation and use thereof
The composition containing a pamoate salt of donepezil, the method of preparation and the use thereof are disclosed.
Organocatalytic asymmetric synthesis of antidepressants
The present invention relates to a short enantioselective synthesis of 1-amino aryl tetraline compounds of Formula 1 via nucleophilic enamine catalysis using organocatalyst such as proline. ##STR00001## wherein R.sub.1 and R.sub.2 represent independent of each other hydrogen, (un)substituted or substituted amine; R.sub.3 and R.sub.4 represent independent of each other hydrogen or halogen.
Organocatalytic asymmetric synthesis of antidepressants
The present invention relates to a short enantioselective synthesis of 1-amino aryl tetraline compounds of Formula 1 via nucleophilic enamine catalysis using organocatalyst such as proline. ##STR00001## wherein R.sub.1 and R.sub.2 represent independent of each other hydrogen, (un)substituted or substituted amine; R.sub.3 and R.sub.4 represent independent of each other hydrogen or halogen.
Organocatalytic asymmetric synthesis of antidepressants
The present invention relates to a short enantioselective synthesis of 1-amino aryl tetraline compounds of Formula 1 via nucleophilic enamine catalysis using organocatalyst such as proline. ##STR00001## wherein R.sub.1 and R.sub.2 represent independent of each other hydrogen, (un)substituted or substituted amine; R.sub.3 and R.sub.4 represent independent of each other hydrogen or halogen.
Nicotinic receptor non-competitive antagonists
The present invention relates to compounds that modulate nicotinic receptors as non-competitive antagonists, methods for their synthesis, methods for use, and their pharmaceutical compositions.
Nicotinic receptor non-competitive antagonists
The present invention relates to compounds that modulate nicotinic receptors as non-competitive antagonists, methods for their synthesis, methods for use, and their pharmaceutical compositions.
LIPID NANOMATERIALS AND USES THEREOF
Disclosed herein are lipid formulations that can be used in drug delivery and screening.
LIPID NANOMATERIALS AND USES THEREOF
Disclosed herein are lipid formulations that can be used in drug delivery and screening.
ANALGESIC COMPOUNDS
Disclosed herein are compounds of Formula (I), methods of synthesizing compounds of Formula (I), and methods of using compounds of Formula (I) as an analgesic.
##STR00001##